Interferon-β regulates the production of IL-10 by toll-like receptor-activated microglia (Q48272369)

10 February 2018

title

Interferon-β regulates the production of IL-10 by toll-like receptor-activated microglia (English)

1 reference

10 February 2018

0 references

0 references

1 reference

10 February 2018

Susana Roque

series ordinal

1 reference

10 February 2018

Diogo Lobo-Silva

0 references

Margarida Saraiva

0 references

Guilhermina M Carriche

series ordinal

1 reference

10 February 2018

publication date

15 June 2017

1 reference

10 February 2018

published in

Glia

1 reference

10 February 2018

volume

1 reference

10 February 2018

issue

1 reference

10 February 2018

page(s)

1439-1451

1 reference

10 February 2018

The microtubule regulator stathmin is an endogenous protein agonist for TLR3.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Broad expression of Toll-like receptors in the human central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

IL-10 alters immunoproteostasis in APP mice, increasing plaque burden and worsening cognitive behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

The immunology of neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Microglial phenotype and adaptation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

IL-27 promotes IL-10 production by effector Th1 CD4+ T cells: a critical mechanism for protection from severe immunopathology during malaria infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Microglial diversity by responses and responders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Fine-tuning of type I IFN-signaling in microglia--implications for homeostasis, CNS autoimmunity and interferonopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Immune tolerance in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

GSK-3 mediates the release of IL-1β, TNF-α and IL-10 from cortical glia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Microglia: active sensor and versatile effector cells in the normal and pathologic brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

A Decade of Research on TLR2 Discovering Its Pivotal Role in Glial Activation and Neuroinflammation in Neurodegenerative Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Toll-like receptor 2 (TLR2)-TLR9 crosstalk dictates IL-12 family cytokine production in microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Differential Production of Type I IFN Determines the Reciprocal Levels of IL-10 and Proinflammatory Cytokines Produced by C57BL/6 and BALB/c Macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

The role of interferon-β in the treatment of multiple sclerosis and experimental autoimmune encephalomyelitis - in the perspective of inflammasomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Lipopolysaccharide-Mediated IL-10 Transcriptional Regulation Requires Sequential Induction of Type I IFNs and IL-27 in Macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

The influence of AAV2-mediated gene transfer of human IL-10 on neurodegeneration and immune response in a murine model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Visualizing production of beta interferon by astrocytes and microglia in brain of La Crosse virus-infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

21 January 2018

Physiology of microglia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Induction of endogenous Type I interferon within the central nervous system plays a protective role in experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Injury-induced type I IFN signaling regulates inflammatory responses in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Pattern recognition receptors and central nervous system repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

IFNβ secreted by microglia mediates clearance of myelin debris in CNS autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Longitudinal interferon-β effects in multiple sclerosis: differential regulation of IL-10 and IL-17A, while no sustained effects on IFN-γ, IL-4 or IL-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

The therapeutic potential of interleukin-10 in neuroimmune diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Expression and regulation of interleukin-10 and interleukin-10 receptor in rat astroglial and microglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Balancing the immune response in the brain: IL-10 and its regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Drug Insight: interferon treatment in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Type I interferons in infectious disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Type I IFN induces IL-10 production in an IL-27-independent manner and blocks responsiveness to IFN-γ for production of IL-12 and bacterial killing in Mycobacterium tuberculosis-infected macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Interferon production during lymphocytic choriomeningitis virus infection of nude and normal mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Type I interferon programs innate myeloid dynamics and gene expression in the virally infected nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

T(H)1 cells control themselves by producing interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Toll-like receptors in neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Immune surveillance in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Microbial sensing by Toll-like receptors and intracellular nucleic acid sensors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

IL-10 deficiency exacerbates the brain inflammatory response to permanent ischemia without preventing resolution of the lesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Interferon-β-1b: a review of its use in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

IFN-beta inhibits human Th17 cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Innate immunity in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Murine Coronavirus Mouse Hepatitis Virus Is Recognized by MDA5 and Induces Type I Interferon in Brain Macrophages/Microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Innate immunity and neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Inflammatory Response in the CNS: Friend or Foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Microglial toll-like receptors and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Differential post-transcriptional regulation of IL-10 by TLR2 and TLR4-activated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Real-life impact of early interferon beta therapy in relapsing multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Proinflammatory Bacterial Peptidoglycan as a Cofactor for the Development of Central Nervous System Autoimmune Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

The Role of Glycogen Synthase Kinase 3 in Regulating IFN-β–Mediated IL-10 Production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Distinct and Nonredundant In Vivo Functions of IFNAR on Myeloid Cells Limit Autoimmunity in the Central Nervous System

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

7 January 2021

TLR signaling tailors innate immune responses in human microglia and astrocytes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

7 January 2021

Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-beta treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

7 January 2021

Production of interleukin-10 by mouse glial cells in culture

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

7 January 2021

IL-27 mediates the response to IFN-β therapy in multiple sclerosis patients by inhibiting Th17 cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

7 January 2021

Cutting Edge: TLR3 stimulation suppresses experimental autoimmune encephalomyelitis by inducing endogenous IFN-beta

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23172

7 January 2021

IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice.

1 reference

12 December 2020

Interactions between TLR7 and TLR9 agonists and receptors regulate innate immune responses by astrocytes and microglia

1 reference

12 December 2020

TLRs as therapeutic targets in CNS inflammation and infection

1 reference

12 December 2020

The role of Toll-like receptors in multiple sclerosis and possible targeting for therapeutic purposes

1 reference

12 December 2020

Identifiers

DOI

10.1002/GLIA.23172

1 reference

10 February 2018

1 reference

10 February 2018